Tatva Chintan Pharma Chem has announced that Chief Financial Officer (CFO) of the company, Mahesh Tanna has tendered his resignation from the post of CFO and Key Managerial Personnel on August 24, 2021.
The company informed in an exchange filing that they have accepted the resignation and Tanna will be relieved from the Company with effect from 31 August, 2021 after closure of working hours.
After the company announced the resignation of Tanna, the Tatva Chintan equities were slipped over 2 percent to rupees 2,086 per share on the BSE index in the opening deals on Wednesday.
The company says that they are in process to appoint his successor as and the same will be informed upon such appointment.
The specialty chemical manufacturing company Tatva Chintan Pharma Chem stocks made a bumper debut in July by breaching nearly 100 percent at listing as against the issue price of rupees 1,083.
The initial public offer (IPO) of rupees 500 crore of the company had received a strong investor response, with the issue getting subscribed by an enormous 180.36 times.
The company based in Vadodara, Gujarat was incorporated in 1996 and is engaged in the manufacturing of a multiple portfolio of structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts and other specialty chemicals (PASC).
The company operates through two manufacturing facilities located at Ankleshwar and Dahej in Gujarat.
The company exports most of its products to more than 25 countries which h alos includes the United States, China, Germany, Japan, South Africa and the United Kingdom.